SMT201600012B - Composti eterociclici come leganti del recettore h3 dell'istamina - Google Patents
Composti eterociclici come leganti del recettore h3 dell'istaminaInfo
- Publication number
- SMT201600012B SMT201600012B SM201600012T SM201600012T SMT201600012B SM T201600012 B SMT201600012 B SM T201600012B SM 201600012 T SM201600012 T SM 201600012T SM 201600012 T SM201600012 T SM 201600012T SM T201600012 B SMT201600012 B SM T201600012B
- Authority
- SM
- San Marino
- Prior art keywords
- istamin
- binders
- receptor
- heterocyclic compounds
- heterocyclic
- Prior art date
Links
- 239000011230 binding agent Substances 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2551CH2010 | 2010-09-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
SMT201600012B true SMT201600012B (it) | 2016-02-25 |
Family
ID=43608695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SM201600012T SMT201600012B (it) | 2010-09-02 | 2016-01-14 | Composti eterociclici come leganti del recettore h3 dell'istamina |
Country Status (26)
Country | Link |
---|---|
US (1) | US8912179B2 (it) |
EP (1) | EP2611444B1 (it) |
JP (1) | JP5650329B2 (it) |
KR (1) | KR101538239B1 (it) |
CN (1) | CN103079566B (it) |
AU (1) | AU2010360038B2 (it) |
BR (1) | BR112013005084A2 (it) |
CA (1) | CA2812970C (it) |
CY (1) | CY1117096T1 (it) |
DK (1) | DK2611444T3 (it) |
EA (1) | EA022746B1 (it) |
ES (1) | ES2558531T3 (it) |
HR (1) | HRP20151380T1 (it) |
HU (1) | HUE028435T2 (it) |
IL (1) | IL224652A (it) |
ME (1) | ME02320B (it) |
MX (1) | MX354852B (it) |
NZ (1) | NZ607658A (it) |
PL (1) | PL2611444T3 (it) |
PT (1) | PT2611444E (it) |
RS (1) | RS54514B1 (it) |
SG (1) | SG188212A1 (it) |
SI (1) | SI2611444T1 (it) |
SM (1) | SMT201600012B (it) |
WO (1) | WO2012029070A1 (it) |
ZA (1) | ZA201301143B (it) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112015001524B1 (pt) * | 2012-08-23 | 2022-04-05 | Suven Life Sciences Limited | Composto de acrilamida, processo para a preparação de um composto de acrilamida, composição farmacêutica e uso de um composto de acrilamida |
CN104530088A (zh) * | 2014-12-08 | 2015-04-22 | 苏州施亚生物科技有限公司 | 2-氨基-6,7-二氢-5H-噻唑并[5,4-b]吡啶-4-羧酸叔丁酯及其衍生物,以及它们的合成方法 |
EP3378477A1 (en) * | 2017-03-21 | 2018-09-26 | BIOPROJET Pharma | New therapeutical use of h3-ligands |
AU2018361364B2 (en) | 2017-11-02 | 2020-11-26 | Aicuris Gmbh & Co. Kg | Novel, highly active amino-thiazole substituted indole-2-carboxamides active against the hepatitis B virus (HBV) |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695575A (en) | 1984-11-13 | 1987-09-22 | Janssen Pharmaceutica, N.V. | 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines |
PH23995A (en) | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
WO2003004480A2 (en) | 2001-07-02 | 2003-01-16 | Novo Nordisk A/S | Substituted piperazine and diazepanes as histamine h3 receptor agonists |
CN1694704A (zh) | 2002-09-06 | 2005-11-09 | 詹森药业有限公司 | (1h-苯并咪唑-2-基)-(哌嗪基)-甲酮衍生物及其相关化合物作为组胺h4受体拮抗剂用于治疗炎性和过敏性疾病 |
MX2007000616A (es) * | 2004-07-16 | 2007-03-07 | Janssen Pharmaceutica Nv | Derivados dimericos de piperidina. |
WO2006008260A1 (en) * | 2004-07-16 | 2006-01-26 | Janssen Pharmaceutica N.V. | Dimeric piperidine derivatives |
CA2601644A1 (en) * | 2005-03-14 | 2006-09-21 | Glaxo Group Limited | Fused thiazole derivatives having affinity for the histamine h3 receptor |
ES2388681T3 (es) * | 2006-03-28 | 2012-10-17 | High Point Pharmaceuticals, Llc | Benzotiazoles con actividad de los receptores de histamina H3 |
US20100009969A1 (en) * | 2006-07-27 | 2010-01-14 | Ucb Pharma, S.A. | Fused Oxazoles & Thiazoles As Histamine H3- Receptor Ligands |
US8314119B2 (en) * | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
US20080146559A1 (en) * | 2006-12-08 | 2008-06-19 | Li Chen | 4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives |
US7557101B2 (en) * | 2006-12-08 | 2009-07-07 | Hoffman-La Roche Inc. | 4,5,6,7-tetrahydro-thieno[3,2-c] pyridine derivatives |
NZ586399A (en) * | 2008-01-24 | 2011-12-22 | Ucb Pharma Sa | Compounds comprising a cyclobutoxy group |
WO2010026113A1 (en) | 2008-09-03 | 2010-03-11 | Evotec Neurosciences Gmbh | Acyl- and sufonyl tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists |
-
2010
- 2010-11-15 HR HRP20151380TT patent/HRP20151380T1/hr unknown
- 2010-11-15 HU HUE10803396A patent/HUE028435T2/en unknown
- 2010-11-15 WO PCT/IN2010/000740 patent/WO2012029070A1/en active Application Filing
- 2010-11-15 PL PL10803396T patent/PL2611444T3/pl unknown
- 2010-11-15 ES ES10803396.0T patent/ES2558531T3/es active Active
- 2010-11-15 CN CN201080068911.8A patent/CN103079566B/zh not_active Expired - Fee Related
- 2010-11-15 MX MX2013001988A patent/MX354852B/es active IP Right Grant
- 2010-11-15 EA EA201390327A patent/EA022746B1/ru not_active IP Right Cessation
- 2010-11-15 CA CA2812970A patent/CA2812970C/en not_active Expired - Fee Related
- 2010-11-15 JP JP2013526597A patent/JP5650329B2/ja not_active Expired - Fee Related
- 2010-11-15 DK DK10803396.0T patent/DK2611444T3/en active
- 2010-11-15 AU AU2010360038A patent/AU2010360038B2/en not_active Ceased
- 2010-11-15 SI SI201031083T patent/SI2611444T1/sl unknown
- 2010-11-15 ME MEP-2015-216A patent/ME02320B/me unknown
- 2010-11-15 KR KR1020137005890A patent/KR101538239B1/ko not_active Expired - Fee Related
- 2010-11-15 BR BR112013005084-5A patent/BR112013005084A2/pt not_active Application Discontinuation
- 2010-11-15 US US13/818,152 patent/US8912179B2/en not_active Expired - Fee Related
- 2010-11-15 RS RS20150868A patent/RS54514B1/en unknown
- 2010-11-15 EP EP10803396.0A patent/EP2611444B1/en active Active
- 2010-11-15 SG SG2013010921A patent/SG188212A1/en unknown
- 2010-11-15 PT PT108033960T patent/PT2611444E/pt unknown
-
2012
- 2012-12-24 NZ NZ607658A patent/NZ607658A/en not_active IP Right Cessation
-
2013
- 2013-02-10 IL IL224652A patent/IL224652A/en not_active IP Right Cessation
- 2013-02-11 ZA ZA2013/01143A patent/ZA201301143B/en unknown
-
2015
- 2015-12-30 CY CY20151101205T patent/CY1117096T1/el unknown
-
2016
- 2016-01-14 SM SM201600012T patent/SMT201600012B/it unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2000032I1 (hu) | Helyettesített 4-fenil-piridinek NK-1 receptorral kapcsolatos betegségek kezelésére | |
PL2593452T3 (pl) | Związki heterocykliczne będące agonistami receptora IP | |
EP2925321A4 (en) | 2-pyridylamino-4-nitrile-piperidinyl orexin receptor antagonists | |
EP2590647A4 (en) | PRO-NEUROGENIC COMPOUNDS | |
EP2934527A4 (en) | 2-pyridyloxy-4-ESTER-orexin receptor antagonists | |
EP2538785A4 (en) | PROCESS FOR THE SYNTHESIS OF DIARYLTHIOHYDANTOIN AND DIARYLHYDANTOINE COMPOUNDS | |
EP2704573A4 (en) | AMINOMETHYL biaryl BENZOTRIAZOL DERIVATIVES | |
EP2723741A4 (en) | SUBSTITUTED IMIDAZOPYRIDINYL-AMINOPYRIDINE COMPOUNDS | |
EP2491025A4 (en) | AZAAZULENVERBINDUNGEN | |
HRP20181788T1 (hr) | Supstituirani spojevi piridinon-piridinil | |
DK2540728T3 (da) | Heterocyklisk forbindelse | |
DK2821407T3 (da) | Piperidinoncarboxamidazaindan-cgrp receptorantagonister | |
EP2555766A4 (en) | ANTI Metastases CONNECTIONS | |
PL2658851T3 (pl) | Związki heterocykliczne odpowiednie do leczenia dyslipidemii | |
EP2616453A4 (en) | ANTI Metastases CONNECTIONS | |
EP2721029A4 (en) | Imidazopyridine-2-ON DERIVATIVES | |
EP2906531A4 (en) | COMPOUNDS FOR SYNTHESIS OF BENZAMIDE COMPOUNDS | |
SMT201600262B (it) | Derivati benzazolici come ligandi del recettore h4 dell'istamina | |
BR112013010643A2 (pt) | compostos heterocíclicos | |
PL2591785T3 (pl) | Zastosowanie 5-androstano(alkilo)-3,5,6-triolu do wytwarzania leków neuroprotekcyjnych | |
SMT201500296B (it) | Antagonisti del recettore trpm8 | |
SMT201500087B (it) | Composti eteroarilici come ligandi del recettore 5-ht4 | |
EP2771346A4 (en) | ISOXAZOLOPYRIDIN-orexin | |
EP2519519A4 (en) | Substituted Naphthalenyl-pyrimidine compounds | |
EP2427183A4 (en) | THERAPEUTIC COMPOUNDS |